An observational, prospective, multicenter study on the utilization and effectiveness of elbasvir–grazoprevir treatment association for chronic hepatitis C in France (ZEPHYR study)

Benoît Dupont (1, 2, 3) , Olivier Dejardin (1, 3) , Véronique Bouvier (1, 3) , Marie-Astrid Piquet (4, 5, 2, 1) , Arnaud Alves (1, 3, 6)

1 UNICAEN - Université de Caen Normandie
2 Service d'Hépato-Gastro-Enterologie et Nutrition [CHU Caen]
3 ANTICIPE - Unité de recherche interdisciplinaire pour la prévention et le traitement des cancers
4 ADEN - Nutrition, Inflammation et axe Microbiote-Intestin-Cerveau
5 IRIB - Institute for Research and Innovation in Biomedicine
6 Service de Chirurgie Viscérale et Digestive [CHU Caen]

Domains: Life Sciences [q-bio]; Human health and pathology; Hépatology and Gastroenterology

Benoît Dupont, Olivier Dejardin, Véronique Bouvier, Marie-Astrid Piquet, Arnaud Alves. An observational, prospective, multicenter study on the utilization and effectiveness of elbasvir–grazoprevir treatment association for chronic hepatitis C in France (ZEPHYR study). Health Science Reports, 2023, 6 (1), pp.819-835. ⟨10.1002/hsr2.619⟩. ⟨hal-03932613⟩